Effectiveness and Safety of Subcutaneous Rituximab for Patients With Gastric MALT Lymphoma: A Case–Control Comparison With Intravenous Rituximab - Université Paris-Est-Créteil-Val-de-Marne Access content directly
Journal Articles Clinical Lymphoma, Myeloma & Leukemia Year : 2021

Effectiveness and Safety of Subcutaneous Rituximab for Patients With Gastric MALT Lymphoma: A Case–Control Comparison With Intravenous Rituximab

Hugo Rotkopf
  • Function : Author
Michaël Lévy
  • Function : Author
Christiane Copie-Bergman
  • Function : Author
Jehan Dupuis
  • Function : Author
Muriel Verlinde-Carvalho
  • Function : Author
Charlotte Gagniere
  • Function : Author
Karim Belhadj
  • Function : Author
Jenny Tannoury
Fabien Le Bras
  • Function : Author
Iradj Sobhani
  • Function : Author
Corinne Haioun
  • Function : Author
Aurelien Amiot
No file

Dates and versions

hal-04395407 , version 1 (15-01-2024)

Identifiers

Cite

Hugo Rotkopf, Michaël Lévy, Christiane Copie-Bergman, Jehan Dupuis, Muriel Verlinde-Carvalho, et al.. Effectiveness and Safety of Subcutaneous Rituximab for Patients With Gastric MALT Lymphoma: A Case–Control Comparison With Intravenous Rituximab. Clinical Lymphoma, Myeloma & Leukemia, 2021, 21 (1), pp.e32-e38. ⟨10.1016/j.clml.2020.08.014⟩. ⟨hal-04395407⟩

Collections

IMRB UPEC
3 View
0 Download

Altmetric

Share

Gmail Facebook X LinkedIn More